Featured
Read our handpicked blogs, curated for you.
|
Pharma marketers in India know the frustration well. Campaigns stall not because the idea is weak, but because the…
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
Recent releases
|
Prescription Uptake Is a Data Problem, Not a Sales Problem
For years, when prescription numbers flatlined, pharma’s first instinct was to push the field force harder. Add more reps. Increase call frequency. Train them better.But here’s the thing: it’s not…
|
Pilot Paralysis Is Costing Pharma Growth. Time to Scale or Stagnate.
Pharma marketing in India has no shortage of pilots. Every quarter, a new “digital-first” idea is tested. A chatbot here. A WhatsApp drip there. Maybe a webinar series that looked exciting on slides…
|
Your Reps Could Be a Digital Engine. Here’s How to Switch It On.
Why the Field Force Alone Can’t Deliver AnymorePharma has always leaned on reps. They’re the frontline, the face doctors see. But here’s the truth CMOs know: rep-only models don’t work like they used…
|
Adherence = Revenue: The Data Case Pharma CMOs Can’t Afford to Miss
Why Adherence is the Real Growth Lever: Let’s call it straight. For all the money pharma spends on marketing, the biggest gap isn’t awareness. It’s adherence. Doctors prescribe. Patients start. But…
